Local media: UC, UC Health to examine potential COVID-19 treatment
In the absence of an approved treatment for COVID-19, in March the FDA began allowing researchers to request emergency authorization for the use of convalescent plasma which shows potential as a treatment for the disease.
Researchers at the UC College of Medicine are among those who joined the Mayo Clinic protocol for investigating convalescent plasma as a possible treatment for COVID-19. Convalescent plasma is obtained from people who have recovered from COVID-19 and have been free of symptoms for 28 days. This program may allow access to that plasma for hospitalized patients infected with the novel coronavirus who have severe or life-threatening COVID-19, or who may be at high risk for progression to severe or life-threatening disease.
This research garnered coverage from the Cincinnati Business Courier, Cincinnati Enquirer, WLWT, Fox19 and WVXU.
Featured image at top from freestocks on Unsplash.
Find the latest details related to coronavirus disease 2019 (covid-19) on the Centers for Disease Control and Prevention (CDC) website, and follow UC's latest information with regard to the virus.
Related Stories
UC graduate earns Fulbright to teach, bridge cultures in rural...
July 15, 2025
Starting in August, University of Cincinnati graduate Perry Li will serve as a Fulbright English Teaching Assistant in Taiwan. He will work with students while acting as a cultural ambassador for the United States.
Don’t fall for these seven myths of research
July 14, 2025
A new publication by two University of Cincinnati researchers contends that adjusting how researchers approach their statistical analysis has the potential to change the lives of children and adolescents struggling with mental health issues across the world. Jeffrey Mills, PhD, and Jeffrey Strawn, MD, have been collaborating on interdisciplinary research and data analysis for years. Their latest paper, “Myths of Randomized Controlled Trial Analysis in Pediatric Psychopharmacology,” was selected as an Editor’s Pick for the Journal of Child and Adolescent Psychopharmacology.
Study finds pregnancy risks higher with ART in kidney transplant...
July 14, 2025
The odds of complications during pregnancy may be increased among women with kidney transplants conceiving through assisted reproductive technology (ART), according to a recent study led by the University of Cincinnati's Silvi Shah, MD, and published in Transplantation.